Orchid receives USFDA approval for Granisetron tablet

MUMBAI: Orchid Chemicals has received approval for abbreviated new drug application--Granisetron Hydrochloride tablets available in 1 mg dosage strength from the USFDA. An anti-emetic product, Granisetron is a new generation non-antibiotic product. The approval for the product has increased the company���s share price by 5.34 per cent at Rs 241.80 on BSE.